Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancerCANCER IMAGINGIF3.52017-05-259OAAI
Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancerBREAST CANCER RESEARCHIF5.62016-08-0523OAAI
The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: A comparison with the radioguided occult lesion localization with 99m technetiumEJSOIF2.92015-04-0134PREAI
Combined use of 18F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapyEuropean Journal of Nuclear Medicine and Molecular ImagingIF7.62014-04-2941PRE
Avoiding preoperative breast MRI when conventional imaging is sufficient to stage patients eligible for breast conserving therapy当常规成像足以对符合保乳治疗条件的患者进行分期时,避免术前乳房MRIEUROPEAN JOURNAL OF RADIOLOGYIF3.32014-02-0115PREAI
FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancerBREASTIF7.92013-10-0178OAAI
Sequential 18F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapyEuropean Journal of Nuclear Medicine and Molecular ImagingIF7.62013-08-0949PRE
Fully automated deformable registration of breast DCE-MRI and PET/CTPHYSICS IN MEDICINE AND BIOLOGYIF3.42013-02-0131PREAI
Pre-treatment imaging and pathology characteristics of invasive breast cancers of limited extent: Potential relevance for MRI-guided localized therapyRADIOTHERAPY AND ONCOLOGYIF5.32012-07-0119PREAI
A practical approach to manage additional lesions at preoperative breast MRI in patients eligible for breast conserving therapy: resultsBREAST CANCER RESEARCH AND TREATMENTIF32010-07-2235OA
The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort studyBREAST CANCER RESEARCH AND TREATMENTIF32008-09-21100PREAI
Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapyRADIOTHERAPY AND ONCOLOGYIF5.32005-05-01159PREAI